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A rapid and efficient immunoassay method for quantification of interferon-2b using surface plasmon 
resonance was developed with BIAcore 3000 as a sensor. Two different levels of anti-interferon 
monoclonal antibody were immobilized onto a CM5 chip using an amine coupling method. Similar 
binding ratio was observed for both the ligand densities. There was no steric hindrance and loss of 
antibody activity even at higher ligand density (> 22,000 RU). The sensitivity of the assay was increased 
up to 45% with the increment in ligand density from 15,400 to 22,360 RU. The binding between 
interferon-2b and anti-interferon monoclonal antibody was predominantly controlled by mass transfer 
rate and the relationship was found linear, ranged from 5 to 400 ng/mL. Total cycle time per analysis 
was less than 8 min and required only 5 L of sample injection.  
 






Human interferon-2b (IFN-2b) is a physiologically 
active protein and it is one of the growth factor that 
comes under the cytokine family. It has excellent antiviral, 
antimicrobial and antitumor actions. As a result, it is being 
used as one of the bio-pharmaceutical drugs for diseases 
like hairy cell leukemia, chronic hepatitis C, chronic 
hepatitis B (Pestka et al., 2004). Many papers have been 
published for the production and purification of IFN-2b 
(Babu et al., 2000; Lim et al., 2000; Liu et al., 2001; 
Srivastava et al., 2005; Cao et al., 2006; Valente et al., 
2006; Cao et al., 2007; Ayed et al., 2008). In all these 
papers, the amount of IFN-2b was quantified either 
using one or combination of methods like bioactivity 
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Srivastava et al., 2005; Cao et al., 2006; Cao et al., 
2007), gel electrophoresis (Lim et al., 2000; Cao et al., 
2006; Valente et al., 2006), western blot (Valente et al., 
2006) and enzyme linked immunosorbent assay (ELISA) 
(Srivastava et al., 2005; Cao et al., 2006; Cao et al., 
2007; Ayed et al., 2008). These methods are time 
consuming. Surface plasmon resonance (SPR) can be 
used to quantify IFN-2b in a similar manner to ELISA 
but with faster rates and consumes fewer reagents. It can 
also be adopted for online monitoring system in a 
production facility (Chavane et al., 2008). 
SPR is used in various fields such as food analysis 
(Taylor et al., 2006), pharmaceutical (Hwang et al., 2005; 
Chavane et al., 2008), environmental monitoring 
(Matsumoto et al., 2005; Shankaran et al., 2006; 
Habauzit et al., 2008), medical diagnostics (Haes et al., 
2005; Yang et al., 2005; Gobi et al., 2007; Masson et al., 
2007) and others (Baird et al., 2002; Beseniar et al., 






to know the binding partners and its relative interaction 
strength for IFNs (Takacs et al., 1999; Asokan et al., 
2006; Schmeisser et al., 2007), immune response 
against IFN- (Gibbs and Oger, 2008) and in one parti-
cular instance to quantify IFN-  (Stigter et al., 2005). 
However, reports on the use of SPR in the quantification 
of IFN-2b are not available in the literature. 
The working principle of SPR can be found elsewhere 
(Habauzit et al., 2007; Ravi Shankaran and Miura, 2007; 
Grieshaber et al., 2008; Homola, 2008). Briefly, the 
system consists of a plane polarized light which is passed 
on to a thin metal layer to get the total internal reflection. 
The angle at which the dip in the intensity of reflection 
occurred is called a SPR angle. This dip is caused by the 
excitation of plasmons that occurs on the thin metal layer. 
The deviation of SPR angle depends on the refractive 
index of the dense medium (glass) and the medium adja-
cent to the metal layer, wavelength and the polarization 
state of the incident light and dielectric constant of the 
thin metal layer. When other factors are kept constant, it 
is clear that the angle shift is only due to the properties of 
the medium adjacent to the metal layer. A shift of 0.1o 
(1000 Resonance unit (RU)) is equivalent to 1 ng/mm2 of 
protein binding (Stenberg et al., 1991). SPR, sensor chip 
and integrated microfluidic channel (IFC) are essential 
components for this type of analysis (Löfås et al., 1991; 
Szabo et al., 1995). While many commercial suppliers 
provide a robust technology for all those components 
(Baird and Myszka, 2001), surface of the sensor chip 
should be modified for one particular use. 
The molecules can be immobilized either on the 
surface of the chip or on the three dimensional layer (free 
moving layer attached on the surface of the chip). 
Although immobilization on the surface is more straight 
forward process, it is often limited by the number of 
recognition sites (Homola, 2008). A linear chain of hydro-
philic carboxymethyl (CM) dextran (hydrogel) is widely 
used to generate a three dimensional layer on the chip 
surface and hence providing a very high surface area for 
immobilization (Shankaran and Miura, 2007). The 
hydrogel requires only very small amount of protein for 
immobilization due to the electrostatic attraction between 
the protein molecules and dextran. Moreover, it suspends 
the ligand in the solution (Stenberg et al., 1991; Rich and 
Myszka, 2007). Yet, the use of hydrogel also comes with 
the limitation of handling more complex crude substances 
due to non specific adsorption (Shankaran and Miura, 
2007) and also due to increase in non specific adsorption 
with respect to time of usage (Masson et al., 2007). In 
some cases, non specific adsorption can be reduced by 
adding CM dextran sodium salt in the samples (Karlsson 
et al., 1993; Yang et al., 2005). To date, BIAcore and 
CM5 chip are most widely used equipment and sensor 
chip (Rich and Myszka, 2005; Rich and Myszka, 2007). 
The surface preparation is the foremost step to have a 
proper concentration assay in SPR (Shankaran and 
Miura, 2007). The   choice  of  appropriate  biorecognition 
elements and immobilization  method  are  of  critical  impor- 




tance with direct impact on key performance 
characteristics of the sensor such as sensitivity, 
specificity, and limit of detection (Homola, 2008). The 
difficulties in the determination of low molecular weight 
analyte (< 20 kDa) at low concentrations using SPR have 
been reported by Huang et al. (2008). They highlighted 
different possible strategies that could be applied to 
enhance the sensitivity and used sandwhich type assay 
to increase the sensitivity of allergens quantification from 
Dermatophagoides farinae (36-40 kDa). Here we des-
cribe a better surface preparation which alone increases 
the sensitivity up to 45% and it offers very simple, low 
cost and lesser running time with very much lower 
volume of reagent than other proposed methods. 
 
 




Anti--IFN Mouse monoclonal antibody (anti-IFN) was purchased 
from Calbiochem (San Diego, CA, USA). CM5 chip and amine 
coupling kit [containing 1-ethyl-3-(3’-dimethylaminopropyl) carbodii-
mide (EDC), N-hydroxysuccinimide (NHS) and 1 M ethanolamine 
hydrochloride (pH 8.5)] were purchased from GE Healthcare 
(Uppsala, Sweden). IFN-2b standard was purchased from Affinity 
Bioreagents (Golden, CO, USA). All other chemicals were pur-
chased either from Sigma-Aldrich (USA) or Merck (USA). HBS-EP 
buffer (10 mM 4-(2 hydroxyethyl)piperazine-1-ethane-sulfonic acid 
(HEPES), 150 mM NaCl, 3 mM ethylenediaminetetraacetic acid 
(EDTA), 0.005% Tween 20, pH 7.4), sodium acetate buffers (10 
mM sodium acetate, with pH 4.0 to 5.5 adjusted by adding 1 M HCl) 
and regeneration buffers were prepared in house, filtered using 
0.22 m filter and degassed prior to use. IFN-2b expressed in 
Escherichia coli strain Rosetta-gami 2 (DE3) containing pET 26b-
IFN vector was used as a crude sample for analysis. The method of 
preparation of this recombinant strain was already described in 
details in our previous study (Ramanan et al., 2010). 
 
 
Instrumentation and software 
 
Biacore 3000 (GE Healthcare) was used in this study. The 
experiments were conducted either using wizard or customized 
program. HBS-EP buffer was selected as continuous running buffer 
at a flow rate of 5 L/min. All experiments were carried out at 25oC 
with CM5 chip and the results were further analyzed using BIA 
evaluation software (Version 4.1). 
 
 
Optimum conditions for immobilization of anti-IFN 
 
The parameters evaluated for optimum conditions for immobilization 
of anti-IFN were buffer pH, flow rate and concentration of anti-IFN. 
The buffer pH was varied from 4.0 to 5.5. The scouting for the 
preferred pH was conducted in 0.1 mg/mL anti-IFN at two different 
flow rates, 20 and 5 L/min. The optimum concentration of anti-IFN 
was searched from 0.020, 0.05 and 0.1 mg/mL at the preferred pH 
(pH 5.0). Fifty mM of NaOH was used as a regeneration solution to 
remove all the electrostatically-adsorbed proteins. 
 
 
Immobilization of anti-IFN 
 
Anti-IFN immobilization was carried out using amine coupling onto 
the CM5 chip. Prior to original immobilization, the chip was exposed 
 




to 2 min (20 L/min) each of 100 mM of HCl, 50 mM of NaOH and 
0.5% SDS to swell the gel (Navratilova et al., 2007). The immo-
bilization procedure was conducted at a flow rate of 5 L/min by 
activating with equal volumes of 100 mM NHS and 400 mM EDC 
mixture followed by immobilization with anti-IFN (0.05 mg/mL 
suspended in 10 mM of acetate buffer pH 5.0) and deactivation of 
unreacted sites with 1 M ethanolamine (pH 8.5). The contact time of 
the different solutions was varied to obtain different ligand densities. 
Immobilization of lower ligand density (LLD) (~15,400 RU) was 
carried out by flowing the activating, immobilizing and deactivating 
solutions for 7, 10 and 7 min, respectively. On the other hand, 
immobilization of higher ligand density (HLD) (~22,360 RU) was 
carried out by flowing 15 min of activating solution, 30 min of immo-
bilizing solution and 10 min of deactivating solution. The reference 
flow cell was prepared either with or without immobilizing solution (1 
mg/mL of BSA at pH 5.0). 
 
 
Selection of regeneration solution 
 
EDTA (20 mM), NaOH (50, 10 and 5 mM) and glycine (10 mM, pH 
3.0 and 2.5) solutions were used for the regeneration scouting. The 
capacity of different regenerating solutions was analyzed by 
passing IFN-2b solution with an approximate increment of 90 RU 
and then passing the particular regenerating solution for 1 min at a 
flow rate of 5 L/min. In order to check their consistency and its 
effect on anti-IFN, similar procedure was repeated for few times. 
 
 
Measurement of standard and sample 
 
Different concentrations of IFN-2b (0 to 400 ng/mL) prepared from 
a standard by diluting with HBS-EP buffer were passed to the 
reference and anti-IFN flow cells for 1 min at a flow rate of 5 L/min. 
IFN-2b expressed in recombinant E. coli was extracted through 
osmotic shock (Ramanan et al., 2009) and glass bead shaking 
(Ramanan et al., 2008). After separating the cells and the 
supernatant by centrifugation (rotor model 1189, Universal 22R 
centrifuge, Hettich AG, Switzerland), the supernatant was mixed 
with HBS-EP buffer in 1:1 ratio and the resultant solution was 
passed to the surfaces similar to the standard. After each 
measurement, the surface was regenerated with one min pulse of 
10 mM glycine (pH 2.5) at 5 L/min. 
All the responses were calculated after subtracting the equivalent 
reference response. The report points were set at 30 s before and 
100 s after the measurement. The end point measurement was 
taken from the difference of two report points. The binding or asso-
ciation rate was taken from the average response rate between 95 
and 110 s from the cycle start time. This is considered to be steady-




Calculation of binding ratio and increase in response 
 
Binding ratio was calculated according to Löfås et al. (1993) using 
equation 1. The molecular weight of anti-IFN and IFN-2b used in 
the equation was 150 and 19 kDa. The response of anti-IFN used in 
the equation for LLD and HLD was 14,618 and 20,963 RU which 
was taken just before the start of experiment. Increase in response 
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RESULTS AND DISCUSSION 
 
Optimum conditions for immobilization of anti-IFN 
 
The main conditions that affect the density of immobilized 
ligand are the concentration of ligand, ionic strength, pH, 
flow rate, activation time and immobilization time. As 
most of these conditions (except the activation time and 
immobilization time) were used to transfer the protein 
from the liquid surface to CM dextran layer, these con-
ditions can be scouted before immobilization by passing 
on to the chip. Low ionic strength was preferred for this 
type of electrostatic attraction (Johnsson et al., 1991; 
Löfås et al., 1993) and it was fixed as 10 mM through out 
the experiment. The pH of the buffer was varied between 
4 and 5.5 to identify the preferred pH for immobilization. 
Generally, this would be assessed for a period of two 
min. At the end of two min run with 20 L/min, most of the 
curves were still in the increasing trend (Figure 1). Higher 
flow through time (> 2 min) was required for some spe-
cific proteins to identify its maximum response (Johnsson 
et al., 1991). In order to identify the maximum response, 
twelve min run was carried out at a flow rate of 5 L/min. 
Although the maximum RU obtained for two min run and 
twelve min run were at similar pH (pH 5.0), the trend was 
different for other pH.  
The difference in charges for dextran and the protein at 
different pH has made the difference in the attraction rate 
and the maximum attraction. For example, the rate of 
attraction was higher at pH 4.0 and 4.5, but the maximum 
attraction was higher at pH 5.0 and 5.5. At lower pH, the 
proteins were more positive (pI ~ 5.0 to 7.0), thus the rate 
of transfer was higher. At similar condition, the total nega-
tive charge of dextran was lower, which in turn, reduced 
the maximum attraction. This is in contrary for the higher 
pH.  
Three different ligand concentrations (0.02, 0.05 and 
0.1 mg/mL) with two different flow rates were run at the 
preferred pH (5.0). Even though the higher attraction rate 
was observed in higher flow rate and at higher concen-
tration, all the maximum attraction response was more 
than 50,000 RU, which was well above the RU that could 
attain after immobilization. Considering the attraction rate 
and cost of antibody, the antibody concentration for 
immobilization experiment was fixed at 0.05 mg/mL with 
a flow rate of 5 L/min.  
 
 
Variation of immobilization level  
 
Two different immobilization levels were attained by vary-
ing the activation and immobilization times. Figure 2 
shows the comparison of maximum protein adsorption 
during scouting and actual immobilization. The maximum 
protein adsorption was reduced during immobilization 
and it was noticed that the reduction was proportional to 
the activation time. The reduction of negative site in CM 
layer by the formation of NHS ester would be the possible 
reason for this. Yet, the maximum immobilization amount  
 






Figure 1. Scouting for the preferred pH at different flow rates and concentrations of anti-IFN performed on CM5 chip using BIAcore 
3000. Two chips were used for these experiments. All experiments were run on the same chip, except the experiment conducted at 
pH 5.0, 50 g/mL, 5 L/min was run using different chip. Scouting was performed at 2, 4 and 12 min. The variations in this scouting 
experiment are as shown in the symbols. Symbols:  pH 4.0,100 g/mL,  5 L/min;     pH 4.5, 100 g/mL, 5 L/min;  pH 
5.0, 100 g/mL, 5 L/min;               pH 5.5, 100 g/mL, 5 L/min;   pH 5.0, 50 g/mL, 5 L/min;  pH 5.0, 20 
g/mL, 5 L/min;   pH 5.0, 100 g/mL, 5 L/min;   pH 4.0, 100 g/mL, 20 L/min;     pH 4.5, 100 g/mL, 20 L/min;           




was increased by increasing the activation time. 
Figures 3a and 3b show the total cycle of immobi-
lization for LLD and HLD, respectively. At 7 min of 
EDC/NHS activation time (Figure 3a), ~15,400 RU was 
obtained which was around 29% of total protein adsorbed  
during scouting. Huang et al. (2008) reported that in 
amine coupling, 60 to 80% of adsorbed protein would be 
immobilized and they had achieved around 62.5%. In 
their study, the optimum conditions were scouted for two 
min interval and information on maximum adsorbed 
protein was not available. In fact, the immobilization 
amount depends on the amount of activated site in the 
chip. Typically, 7 min run of activation solution may 
activate 30 to 40% of CM dextran (Johnsson et al., 1991) 
and the immobilized amount would attain the similar 
percentage.  
Higher immobilization (~22,360 RU) (Figure 3b) was 
achieved by increasing the activation time to 15 min and 
immobilization time to the maximum of 30 min. It should 
be noted that the half life period of activated NHS is 15 
min (Johnsson et al., 1991). In this study, no  changes  in  
the immobilized  amount  were  observed  when  immobi- 
lization was extended more than 30 min.  
 
 
Selection of better regeneration condition 
 
The ideal regeneration condition should be in such a way 
that it should remove all the analyte bound during the 
injection step and it should not affect the binding capacity 
of the ligand. It was observed that the use of chelating 
solution (20 mM EDTA) did not significantly remove the 
analyte. On the other hand, the use of high pH caused 
the removal of the ligand. These two conditions affect the 
successive analysis. The use of low pH gave the 
satisfactory result. Subsequently pH 2.5 was chosen after 
showing the consistent response for 5 successive cycles 
(Figure 4). Though this test was performed at the 
increment of 90 RU, 5 L of regeneration solution was 
found to be effective until 600 RU. The incomplete 
regeneration for higher response was observed, even 
after several injections of regeneration solution (glycine, 
pH 2.0) (Gobi et al., 2007). Similar observation  was  also  
 








Figure 2. Comparison of immobilization and pH scouting of anti-IFN performed on CM5 chip using BIAcore 3000. 
Symbols:  Response of protein adsorption during pH scouting;  Response of protein adsorption during immobilization 




noted in this study. For higher response, even though 
incomplete regeneration was observed, 8 L of regene-




Activity of immobilized ligand  
 
The ligand activity is generally affected by the activation 
time and the amount of immobilized ligand. Since the amine 
coupling immobilize the ligand randomly, the reduction of 
activation time would reduce the cross-linking of ligand and 
increase the activity but reduce the amount of immobi-
lized ligand (Löfås et al., 1995). On the other hand, 
higher immobilized ligand would shift the response from 
kinetics limited to mass transfer limited assay which 
would be good for concentration assay (Karlsson et al., 
1993). Higher immobilized ligand would also increase the 
sensitivity of assay (Löfås et al., 1993) but in some cases 
the sensitivity would be reduced due to the steric hind-
rance of the ligand itself (Löfås et al., 1993; Johnsson et 
al., 1995; Yarmush et al., 1996).  
The binding ratio between the analyte and the immobi-
lized ligand was found to be similar for both the ligand 
density, though the total amount of analyte bound was 
increased at a particular concentration (Figure 5). The 
average sensitivity was increased to 40% (Table 1) by 
simply immobilizing higher ligand density. Karlsson et al. 
(1993) reported that the increment of ligand density 
would lead to mass transfer limited reaction only and the 
binding rate observed would be independent of the 
amount of ligand density. Results from this study showed 
that this was not achieved for this interaction even up to 
22,360 RU (Table 1).  
Hwang et al. (2005) observed no reduction in ligand 
activity for the quantification of hepatitis B surface antigen 
(~22 kDa) up to 17,600 RU. In this study, similar result 
was also observed up to 22,360 RU. In fact, the results 
from Löfås et al. (1993) delineated that the maximum 
immobilized ligand activity depends on the mass of 
analyte for antibody and antigen interaction. 
 
 
Inclusion of reference surface 
 
The subtraction of response of the actual surface from 
the reference surface is useful to remove the non-specific 
adsorption on the chip and it is very important while 
analyzing the crude samples. The reference surfaces 
used by some of the previous studies were blank surface 
(Huang et al., 2007), deactivated surface (Yang et al., 
2005; Chavane et al., 2008) and also other antibodies 
(Gonzales et al., 2002; Hwang et al., 2005). The usage of 
other antibodies would mimic their specific surface but 
the cost would be high for long run. In this study, 
deactivated surface and bovine serum albumin (BSA) 
have been used as the reference surface in two different 
chips and observed that the increment of response after 
regeneration in the reference surface in long run. This 
was observed only when low pH was used during 
regeneration and it was less pronounced with the addition 
of 1 M NaCl in the regeneration buffer. At low pH, some 
proteins were denatured and would be bound back in the  
 














Figure 3(a and b). Total cycle of immobilization for LLD (a) and HLD (b) performed on CM5 chip using BIAcore 3000. 1- Response 
during the flow of activation solution (NHS/EDC). 2- Response during the flow of immobilizing solution (Anti-IFN). 3- Response during 
the flow of deactivating solution (Ethanol amine). 
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Figure 4. Baseline and response levels (Y axis) during 5 consecutive cycles (X axis) of 
analyte addition (5 L/min, 1 min) followed by regeneration solution (10 mM glycine, pH 2.5, 
5 L/min, 1 min) performed on LLD of CM5 chip using BIAcore 3000. The baseline and 















Figure 5. Response of different IFN-2b concentrations passed on LLD and HLD of CM5 chip using BIAcore 3000. The 
responses 1 to 9 (reference subtracted) were generated by passing the standards (in triplicates) from 150 to 0 ng/mL to both 
LLD and HLD. The standards were diluted serially from 150 to 1.17 ng/mL and running buffer was used for 0 ng/mL. Symbols 
a and b refer to the response of LLD and HLD for the particular IFN-2b concentration. The concentrations with respect to the 
points 1 to 9 are 150, 75, 37.5, 18.75, 9.38, 4.69, 2.34, 1.17 and 0 ng/mL.  
 




Table 1. Calculation of binding rate, end point response and binding ratio of both ligand densities for different IFN-





Binding rate RU/S End point response RU Binding ratio 
Increase in 
response (%) LLD HLD LLD HLD LLD HLD 
150 3.92 5.18 224.31 303.46 0.121 0.114 35 
75 1.62 2.20 100.14 137.64 0.054 0.052 37 
37.5 0.75 1.07 53.45 73.61 0.029 0.028 38 
18.75 0.32 0.51 30.21 42.57 0.016 0.016 41 
9.38 0.17 0.29 20.46 29.33 0.011 0.011 43 
4.69 0.02 0.09 13.92 20.16 0.008 0.008 45 
2.34 0.01 0.09 12.91 18.04 0.007 0.007 40 
1.17 0.01 0.06 12.80 17.62 0.007 0.007 38 
0.00 -0.10 -0.04 8.99 10.95   22 
 
The binding rate and end point response were taken from the Figure 5. Binding rate was calculated from the average 
response rate between 95 and 110 s. End point response was calculated from the difference between after 100 s and before 
30 s of injection. Binding ratio and increase in response was calculated using equation 1 and 2. Percentage Coefficient of 
Variance (%CV) was found to be less than 6% for all the standards using end point response where as in the binding rate 




Table 2. Quantification of IFN-2b in the samples using binding rate and end point response standard 
curves from HLD (Figure 6). 
 







1 1.73 54.24 93.24 45.14 
2 4.01 119.97 222.53 111.97 
3 5.59 165.81 309.98 157.17 
4 4.36 130.26 237.01 119.45 
5 1.95 60.61 105.51 51.48 
6 5.79 171.47 317.26 160.93 
7 2.51 76.73 132.10 65.23 
8 2.45 74.92 144.35 71.56 
9 2.66 81.09 149.78 74.37 
10 3.38 101.92 188.57 94.42 
11 2.67 81.33 146.34 72.59 
12 5.12 152.11 265.86 134.36 
13 2.58 78.86 149.88 74.41 
14 1.50 47.70 89.73 43.33 
15 4.03 120.56 227.98 114.79 
 





reference cell. Similar problem was also reported by 
Gonzales et al.  (2002). However, this situation did not 
affect the actual assay. 
 
 
Standard curve and sample determination 
 
A standard curve was constructed using IFN-2b stan-
dard at concentration ranging from 0 to 150 ng/mL where 
a linear relationship was observed with respect to its RU. 
In fact, linearity was found up to the maximum concen-
tration analyzed (400 ng/mL). Both the initial binding rate 
(slope) and the end point measurement could be taken in 
constructing the standard curve (Figure 6). As shown in 
Table 2 both measurements gave comparable results. 
While additional steps were needed to calculate the 
binding rate, there was no further step to generate the 
end point measurement. Moreover, the slope end point 
measurement was high with respect to the binding rate. 
Hence the  calibration  and  quantification  using  end  point 
 



























































Figure 6. Standard curves using end point response and binding rate for 
both ligand densities. The values from Table 1 were used to construct the 
standard curve. The error bar shows the standard deviation among the 
samples, run in triplicates. Symbols: () End point response for LLD, ( ) 











Results from this study have demonstrated that the surface 
Preparation is a key step in SPR analysis. With the 
proper design, the sensitivity could be increased and 
thereby reducing the cost of analysis. The sensitivity of 
the analysis could be increased by immobilizing higher 
ligand density. The quantification of IFN-2b in the samples 
could be analyzed by the determination of end point 
measurement. This is mainly due to the interaction 
between the IFN-2b and anti-IFN is predominantly 
controlled by mass transfer rate. Further work will be 
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